Certolizumab Pegol for the Treatment of Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials

Main Article Content

Andrew Blauvelt
Kristian Reich
Mark Lebwohl
Daniel Burge
Catherine Arendt
Luke Peterson
Robert Rolleri
Alice Gottlieb


certolizumab, psoriasis, clinical trial


Abstract not available.


Disclosures: Study sponsored by UCB Pharma.


Copyright 2018 SKIN

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>